Literature DB >> 28734627

The impact of frailty on functional survival in patients 1 year after cardiac surgery.

James Lytwyn1, Andrew N Stammers2, D Scott Kehler2, Patrick Jung1, Bryce Alexander1, Brett M Hiebert1, Chris Dubiel1, Dustin Kimber1, Naomi Hamm2, Mekayla Clarke1, Carly Fraser1, Brittany Pedreira1, Todd A Duhamel2, Navdeep Tangri3, Rakesh C Arora4.   

Abstract

OBJECTIVE: This study determined whether frailty provides incremental value to the European System for Cardiac Operative Risk Evaluation II in identifying patients at risk of poor 1-year functional survival.
METHODS: This prospective study in patients undergoing cardiac surgery defined frailty using 3 common definitions: (1) the Modified Fried Criteria; (2) the Short Physical Performance Battery; and (3) the Clinical Frailty Scale. The primary outcome was functional survival, defined as being alive at 1 year postsurgery with a health-related quality of life score greater than 60 on the EuroQol-Visual Analogue Scale.
RESULTS: Of the 188 participants, 49.5%, 52.6%, and 31.9% were deemed frail according to the Modified Fried Criteria, Short Physical Performance Battery, and Clinical Frailty Scale, respectively. The median age of our cohort was 71.0 years (29.3% female). The probability of functional survival at 1 year for the entire cohort was 73.9%. After adjusting for the European System for Cardiac Operative Risk Evaluation II, patients deemed frail under the Modified Fried Criteria, Short Physical Performance Battery, and Clinical Frailty Scale had an increased odds ratio for poor functional survival of 3.44, 3.47, and 2.08, respectively. When compared with the European System for Cardiac Operative Risk Evaluation II alone, the Modified Fried Criteria, Short Physical Performance Battery, and Clinical Frailty Scale showed an absolute improvement in the discrimination slope of 6.7%, 6.5%, and 2.4% with a category-free classification improvement of 59.6%, 59.2%, and 35.1%, respectively.
CONCLUSIONS: Preoperative frailty was associated with a 2- to 3.5-fold higher risk of poor functional survival 1 year after cardiac surgery. The addition of frailty to the European System for Cardiac Operative Risk Evaluation II provides incremental value in identifying patients at risk of poor functional survival 1 year postsurgery, regardless of frailty definition.
Copyright © 2017 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  HRQoL; cardiac surgery; frailty; long-term outcomes; survival

Mesh:

Year:  2017        PMID: 28734627     DOI: 10.1016/j.jtcvs.2017.06.040

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  18 in total

1.  Physical performance as a predictor of midterm outcome after mitral valve surgery.

Authors:  Kohei Ashikaga; Mike Saji; Shuichiro Takanashi; Masatoshi Nagayama; Yoshihiro J Akashi; Mitsuaki Isobe
Journal:  Heart Vessels       Date:  2019-04-10       Impact factor: 2.037

Review 2.  Frailty in the End-Stage Lung Disease or Heart Failure Patient: Implications for the Perioperative Transplant Clinician.

Authors:  Brandi A Bottiger; Alina Nicoara; Laurie D Snyder; Paul E Wischmeyer; Jacob N Schroder; Chetan B Patel; Mani A Daneshmand; Robert N Sladen; Kamrouz Ghadimi
Journal:  J Cardiothorac Vasc Anesth       Date:  2018-08-09       Impact factor: 2.628

3.  Psoas Muscle Size Predicts Risk-Adjusted Outcomes After Surgical Aortic Valve Replacement.

Authors:  Robert B Hawkins; J Hunter Mehaffey; Eric J Charles; John A Kern; D Scott Lim; Nicholas R Teman; Gorav Ailawadi
Journal:  Ann Thorac Surg       Date:  2018-03-09       Impact factor: 4.330

4.  Frailty Is a Risk Factor for Postoperative Mortality in Patients With Cirrhosis Undergoing Diverse Major Surgeries.

Authors:  Nadim Mahmud; David E Kaplan; Tamar H Taddei; David S Goldberg
Journal:  Liver Transpl       Date:  2021-02-15       Impact factor: 5.799

5.  Surviving and Thriving 1 Year After Cardiac Surgery: Frailty and Delirium Matter.

Authors:  Hsiu-Ching Li; Yu-Chung Wei; Ron-Bin Hsu; Nai-Hsin Chi; Shoei-Shen Wang; Yih-Sharng Chen; Ssu-Yuan Chen; Cheryl Chia-Hui Chen; Sharon K Inouye
Journal:  Ann Thorac Surg       Date:  2020-09-17       Impact factor: 4.330

6.  Improvement in Physical Function After Coronary Artery Bypass Graft Surgery Using a Novel Rehabilitation Intervention: A RANDOMIZED CONTROLLED TRIAL.

Authors:  Jason L Rengo; Patrick D Savage; Fuyuki Hirashima; Bruce J Leavitt; Philip A Ades; Michael J Toth
Journal:  J Cardiopulm Rehabil Prev       Date:  2021-11-01       Impact factor: 2.081

7.  Frailty as a Predictor of Postoperative Outcomes in Invasive Cardiac Surgery: A Systematic Review of Literature.

Authors:  Anna Peeler; Chandler Moser; Kelly T Gleason; Patricia M Davidson
Journal:  J Cardiovasc Nurs       Date:  2022 May-Jun 01       Impact factor: 2.468

8.  Frailty and perioperative patient-reported disability in patients undergoing cardiac surgery: a pilot study.

Authors:  Benjamin Milne; Joshua Lucas de Carvalho; Salma Ayis; Sanjay Chaubey; Habib Khan; Gudrun Kunst
Journal:  Br J Anaesth       Date:  2022-04-21       Impact factor: 11.719

9.  Gait Speed Is Not Associated with Vasogenic Shock or Cardiogenic Shock following Cardiac Surgery, but Is Associated with Increased Hospital Length of Stay.

Authors:  Kimmie Clark; Taylor Leathers; Duncan Rotich; Jianghua He; Katy Wirtz; Emmanuel Daon; Brigid C Flynn
Journal:  Crit Care Res Pract       Date:  2018-10-23

10.  Value of a comprehensive geriatric assessment for predicting one-year outcomes in patients undergoing transcatheter aortic valve implantation: results from the CGA-TAVI multicentre registry.

Authors:  Martijn S van Mourik; Nathalie van der Velde; Giulio Mannarino; Marie-Pierre Thibodeau; Jean-Bernard Masson; Gennaro Santoro; Jan Baan; Sofie Jansen; Jana Kurucova; Martin Thoenes; Cornelia Deutsch; Andreas W Schoenenberger; Andrea Ungar; Peter Bramlage; M Marije Vis
Journal:  J Geriatr Cardiol       Date:  2019-06       Impact factor: 3.327

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.